Jianhai Technology
健海科技
Jianhai Technology is an AI-powered disease management platform that raised at least three disclosed venture rounds between 2020 and 2021, per Source Code Capital's announcements. It closed a RMB 60 million Series A3 in September 2020 led by Source Code Capital with Sherpa Healthcare Partners following on , then a RMB 150 million Series B in March 2021 led by Sequoia China (HSG) with Source Code Capital increasing its stake , and a RMB 500 million Series B+ later that year with Source Code Capital again adding to its position alongside follow-on investors including HSG, Sanchuang Health, and Guoce Investment . Source Code Capital, which first backed the company in its A3 round, has repeatedly highlighted Jianhai as part of its broader healthcare and "tech + biotech" portfolio alongside the likes of WeDoctor, METiS, and Silicon-based Bionic . The company's positioning as a disease management platform suggests it sits at the intersection of digital health and clinical care coordination, though elsewhere's corpus does not contain more recent operational or strategic details beyond this 2020–2021 fundraising arc.
AI-generated — may contain errors, please verify.
Coverage
Code Moment | Congratulations to METiS Pharmaceuticals on Its HKEX Listing, the World's First AI Drug Delivery Stock
Source Code Capital participated in METiS Pharmaceuticals' angel round in 2020 and continued to increase its stake in subsequent rounds.
Source Code Capital "Tech + Bio-Med" Investment Open Day Now Accepting Applications
"The Tech + Biotech" Crossover: A New Investment Consensus on Convergent Innovation
Professional, systematic, and patient for the long haul.
Data tech company XSKY closes RMB 400 million Series F funding round with Source Code Capital participation
Data Evergreen
Semiconductor tech company **Raytron** announced the completion of a Pre-A funding round in the tens of millions of dollars. Source Code Capital was the sole investor in its angel round.
Specializes in Micro-LED microdisplay chip architecture design, process development, and monolithic full-color technology research.
Xianglu Technology, a robotics R&D and application company, announced the completion of a 100-million-yuan angel funding round, with Source Code Capital as the sole investor.
Live Better with Robots
Photonics technology company **Kunyao Optoelectronics** announced the completion of a nearly RMB 400 million Series B+ funding round, with participation from Source Code Capital.
Dedicated to exploring cutting-edge photonics and optoelectronics, and driving their real-world implementation and innovative applications.
Source Code Capital portfolio company Jianhai Technology announced the completion of a 500 million RMB Series B+ funding round, with existing shareholder Source Code Capital continuing to increase its stake.
The "Baike Thousand Courtyards" initiative is about to launch.
Source Code Capital closes fifth RMB fund, raising over 7 billion yuan to back tech innovation and SMEs
Invest early, invest small, invest in tech
Biren Technology, a general-purpose intelligent chip design company, announced the completion of its Series B funding round — Source Code Capital participated in the investment.
Founded just over a year ago, it has raised more than 4.7 billion yuan in total funding.
Daily Black Chocolate Raises Over 100 Million Yuan in Series A+ and B Rounds, Source Code Capital Leads Series A+
China's top-selling dark chocolate category on 2020 Double 11
Source Code Capital Portfolio Company YiCan Closes Nearly $10 Million Series A, with Existing Investor Source Code Capital Increasing Stake
The platform has served more than 1,500 enterprise clients across a wide range of industries, including enterprise services, artificial intelligence, e-commerce, healthcare, automotive and transportation, food & beverage and retail, education, and finance.
Source Code Capital portfolio company Jianhai Technology announced the completion of a 150 million yuan Series B investment, with existing shareholder Source Code Capital continuing to increase its stake.
Dedicated to advancing post-diagnosis disease management systems for patients, it has already partnered with more than 1,000 hospitals.
Source Code Capital portfolio company GalaxySpace announces new funding round, with existing shareholder Source Code Capital continuing to increase its stake
GalaxySpace, the first unicorn in China's commercial aerospace and satellite internet sectors, has now entered the final assembly phase for its second self-developed broadband communications satellite.
Domestic skincare brand PMPM raises tens of millions of yuan in pre-A and pre-A+ rounds, with Source Code Capital as sole angel investor
Launched less than six months ago, it has accumulated nearly RMB 50 million in GMV, growing 100x in just over six months.
AI-powered disease management platform "Jianhai Technology" announces completion of RMB 60 million Series A3 funding round, led by Source Code Capital
It covers over 400 hospitals at or above the second-tier grade, and is exploring the use of AI for disease management and treatment.
